Chimeric Antigen Receptor (CAR) T-cell Therapy

First oral GLP-1 treatment approved for type2 Diabetes

Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail • One Comment

The US FDA has approved Rybelsus (semaglutide) oral tablets to improve blood sugar in adult patients with Type II Diabetes. Rybelsus is an...

Read More

Can commoners afford to spend million dollars on GENE Therapy?

Articles, Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, DelveInsight's Drug Report, Pharma Consultant

Each country has a unique system, politics, and economy. Different policies are designed to suit people of different countries. Same goes...

Read More

Notizia

Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, DelveInsight's Drug Report, Notizia, Pharma Consultant

Anylam, Regeneron to broaden the scope of R&D in Pharma Alnylam in collaboration with Regeneron is expanding its research on NASH....

Read More

The Business Cocktail

Business Consultant, Chimeric Antigen Receptor (CAR) T-cell Therapy, Pharma Consultant

BridgeBio bags USD 299 Million for genetic diseases BridgeBio Pharma has received a USD299.2 million for its progress in genetic...

Read More

Chimeric Antigen Receptor T-cell Therapy Landscape

Chimeric Antigen Receptor (CAR) T-cell Therapy

In the field of oncology, no other approach is as attentive as Immunotherapy. Renewed interest in immunotherapy has been driven by Chimeric...

Read More
Close